Indefinite Delivery Contract 36C25721D0118
- Not listed
- The Department of Veterans Affairs (VA) awarded a single-award Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation for the provision of point-of-care (POC) glucose testing products and services. The $564,845.90 ceiling value contract has a period of performance through May 2025. The IDC was awarded through full and open competition to Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, laboratory instruments, and associated products and services. The...
- This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, laboratory instruments, and associated medical products. The IDC has a ceiling value of $1,170,000 and a period of performance through September 30, 2026. The contract provides for the delivery of reagents, supplies, and consumables for Roche-manufactured...
- This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 (VISN 9) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The single-award IDC has a ceiling value of $2,403,690 and a period of performance ending on March 31, 2026. It is for the procurement of Roche reagents and stainers to support laboratory operations and diagnostic testing services for veterans...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 awarded Roche Diagnostics Corporation a single award indefinite delivery contract with a potential value of $204,616 to provide CoaguChek and Accu-Chek supplies. The base period of performance is from October 1, 2020 through September 30, 2024 with three optional years for ordering. No set-aside provisions were applied. Under the contract, Roche Diagnostics has been issued four firm fixed...
- This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $415,022.25 contract has a period of performance from September 1, 2024 to August 31, 2027 and is for the provision of Roche Diagnostics' COVID-19 reagents and Cobas supplies to the VA. Roche Diagnostics has been awarded numerous...
- The Department of Veterans Affairs (VA) Veterans Integrated Service Network 6 has awarded a single-award Indefinite Delivery Contract (IDC) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and related laboratory equipment and supplies. The IDC, valued at up to $3,272,813.29, has a period of performance through September 30, 2025 and allows the agency to issue delivery orders for Roche's products and services on an as-needed basis. Under this IDC, the VA has...
- The indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 20 to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics. The single-award IDC has a ceiling value of $450,000 and a period of performance through September 30, 2030. The contract is for the procurement of reagents and consumables for laboratory testing, with a specific task order valued at $450,000 for rapid molecular...
- The Department of Veterans Affairs (VA) awarded Roche Diagnostics Corporation, a leading manufacturer of in vitro diagnostics and medical laboratory equipment, an Indefinite Delivery Contract (IDC) valued at $2,821,000.00. The contract covers the provision of ROCHE CONSUMABLES, including diagnostic test kits, reagents, and laboratory instruments, to support medical testing services at VA facilities. Roche Diagnostics holds multiple IDCs and Blanket Purchase Agreements (BPAs) with the VA and...
- The federal contract IDV award was issued by the Department of Veterans Affairs Veterans Health Administration (VA-VHA) Veterans Integrated Service Network 9 to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory instruments. The $733,089.60 single-award IDC has an ultimate completion date of July 31, 2024 and does not utilize any set-aside designations. Under this IDC, Roche Diagnostics has been awarded multiple firm fixed price...
- This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 20 to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics and medical laboratory products. The contract, valued at a ceiling of $534,276, is for the provision of reagents, consumables, and supplies for whole blood glucose testing at VA medical facilities within VISN 20. The original solicitation, issued under NAICS...
- 36C25721D0118Indefinite Delivery Contract
- 4Federal Contract Awards
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA), Veterans Integrated Service Network 17 to Roche Diagnostics Corporation, a global manufacturer of in vitro diagnostics, laboratory instruments, and medical products. The contract, valued at a ceiling of $116,640, provides ACCU-CHEK INFORM II test strips to support the VA's diabetes care programs for veterans. The contract includes a base period from September 15, 2021 to September 14, 2022, with four one-year option periods that can extend the contract through September 14, 2026. The contract does not have any set-aside requirements, indicating Roche Diagnostics competed openly in the federal marketplace. Task orders issued under this IDC have a total value of $184,984 to date, covering the base period and two option year periods. The contracted test strips will be delivered to VA facilities in Temple, Texas to meet the healthcare needs of enrolled veterans across the VA's integrated service network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Exercise an Option | $0 | 8/5/25 | |
| P00002 | Exercise an Option | $0 | 8/20/24 | |
| P00001 | Exercise an Option | $0 | 9/13/23 | |
| Not listed | Not listed | $0 | 9/14/21 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order 36C25721D0118-36C25725N0444 | Roche Diagnostics Corporation | $23.3k | 9/15/25 | 9/14/26 | 8/5/25 | |
Delivery Order 36C25721D0118-36C25723N0487 | Roche Diagnostics Corporation | $23.3k | 9/15/23 | 9/14/24 | 9/13/23 | |
Delivery Order 36C25721D0118-36C25721N0718 | Roche Diagnostics Corporation | $138.3k | 9/14/21 | 9/14/23 | 7/17/25 | |
Delivery Order 36C25721D0118-36C25724N0411 | Roche Diagnostics Corporation | $23.3k | 9/15/24 | 9/14/25 | 8/20/24 |